why choose us

First received: July 31, 2022

Clinical Trial: Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Kidney Diseases
Kidney Transplant; Complications
COVID-19
Vaccine Adverse Reaction

Study Type: Observational


Official Title: Assessment of Association Between 3rd Dose of mRNA Vaccine and Risk of SARS-CoV-2 Infection in Kidney Transplant Recipients, Safety and Immunogenicity Assessment.

Brief Summary: Prospective observational trial to assess immunological safety (anti-HLA antibodies, donor-derived cell-free DNA) and immunological effectiveness (anti-SARS-CoV-2 IgG) of the first booster dose of SARS-CoV-2 mRNA vaccines in kidney transplant recipients at least one year from transplantation.

Read more